| 英文别名 |
DB14017;(2S,3S,6S,7R,10R,E)-7,10-Dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(pyridin-2-yl)hepta-2,4-dien-2;H3B-8800;1-Piperazinecarboxylic acid, 4-methyl-, (2S,3S,4E,6S,7R,10R)-7,10-dihydroxy-3,7-dimethyl-2-((1E,3E,5R)-1-methyl-5-(2-pyridinyl)-1,3-hexadien-1-yl)-12-oxooxacyclododec-4-en-6-yl ester;UNII-90YLS47BRX;SCHEMBL17255784;(2S,3S,4E,6S,7R,10R)-7,10-Dihydroxy-3,7-dimethyl-12-oxo-2-[(2E,4E,6R)-6-(2-pyridinyl)-2,4-heptadien-2-yl]oxacyclododec-4-en-6-yl 4-methyl-1-piperazinecarboxylate;Splicing Inhibitor H3B-8800;(2S,3S,4E,6S,7R,10R)-7,10-Dihydroxy-3,7-dimethyl-12-oxo-2-((2E,4E,6R)-6-(2-pyridinyl)-2,4-heptadien-2-yl)oxacyclododec-4-en-6-yl 4-methyl-1-piperazinecarboxylate;H3B 8800 [WHO-DD];H3B-8800 [WHO-DD];Splicing Factor Inhibitor H3B-8800;(2S,3S,4E,6S,7R,10R)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((4E,6R)-6-(pyridin-2-yl)hepta-2,4-dien-2-yl)-1-oxacyclododec-4-en-6-yl 4-methylpiperazine-1-carboxylate;90YLS47BRX;H3B-8800?;(2S,3S,4E,6S,7R,10R)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-[(4E,6R)-6-(pyridin-2-yl)hepta-2,4-dien-2-yl]-1-oxacyclododec-4-en-6-yl 4-methylpiperazine-1-carboxylate;(2S,3S,4E,6S,7R,10R)-7,10-Dihydroxy-3,7-Dimethyl-12-Oxo-2-[(2E,4E,6R)-6-(Pyridin-2-Yl)Hepta-2,4-Dien-2-Yl]Oxacyclododec-4-En-6-Yl 4-Methylpiperazine-1-Carboxylate;EX-A8015;1825302-42-8;[(2S,3S,4E,6S,7R,10R)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-[(2E,4E,6R)-6-pyridin-2-ylhepta-2,4-dien-2-yl]-1-oxacyclododec-4-en-6-yl] 4-methylpiperazine-1-carboxylate;(2S,3S,4E,6S,7R,10R)-7,10-Dihydroxy-3,7-Dimethyl-12-Oxo-2-((2E,4E,6R)-6-(Pyridin-2-Yl)Hepta-2,4-Dien-2-Yl)Oxacyclododec-4-En-6-Yl 4-Methylpiperazine-1-Carboxylate;HY-111517;H3B8800;Splicing Modulator H3B-8800;CS-0042315 |
微信公众号
客服
